Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-039233
Date:2021-06-08
Issuer: AEGLEA BIOTHERAPEUTICS, INC. (AGLE)
Original Submission Date:

Reporting Person:

SHANAFELT ARMEN
C/O LILLY VENTURES
115 W WASHINGTON STREET, SUITE 1680 SOUTH INDIANAPOLIS, IN 46204

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
DIRECTOR STOCK OPTION (RIGHT TO BUY) 6.8 2021-06-08 deemed execution date A 40,000 (a) 2031-06-07 common stock 40,000 $6.80 40,000 direct
Footnotes
IDfootnote
f1 the stock option vests and becomes exercisable in 12 equal monthly installments beginning on july 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the reporting person on each vesting date.
WhaleWisdom Logo

Elevate your investments